PGE2 inhibits natural killer and γδ T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling
- 1 September 2010
- journal article
- research article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 80 (6), 838-845
- https://doi.org/10.1016/j.bcp.2010.05.002
Abstract
No abstract availableKeywords
Funding Information
- Institut National de la Santé et de la Recherche Médicale
- Institut National Du Cancer
This publication has 44 references indexed in Scilit:
- Oncogenic stress sensed by the immune system: role of natural killer cell receptorsNature Reviews Immunology, 2009
- A regulatory cross‐talk between Vγ9Vδ2 T lymphocytes and mesenchymal stem cellsEuropean Journal of Immunology, 2009
- Up on the tightrope: natural killer cell activation and inhibitionNature Immunology, 2008
- Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancerAnnals of Oncology, 2007
- Adenosine-Mediated Inhibition of the Cytotoxic Activity and Cytokine Production by Activated Natural Killer CellsCancer Research, 2006
- E prostanoid 2 (EP2)/EP4‐mediated suppression of antigen‐specific human T‐cell responses by prostaglandin E2Immunology, 2006
- Activated γδ T cells express the natural cytotoxicity receptor natural killer p44 and show cytotoxic activity against myeloma cellsClinical and Experimental Immunology, 2006
- NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cellsNature Immunology, 2006
- The DNA damage pathway regulates innate immune system ligands of the NKG2D receptorNature, 2005
- Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated CytolysisAnnual Review of Immunology, 2001